From: Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's disease
Compound 13
Compound 21
Lipinski violations
0
Ghose violations
Veber violations
Egan violations
Muegge violations
Lead-likeness violations
1
2
PAINS alerts
Synthetic accessibility
3.30
2.85